Fendiline, an anti-anginal drug, increases intracellular Ca2+ in PC3 human prostate cancer cells

C. R. Jan, K. C. Lee, K. J. Chou, J. S. Cheng, J. L. Wang, Y. K. Lo, H. T. Chang, K. Y. Tang, C. C. Yu, J. K. Huang*

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Fendiline, an anti-anginal drug, increases intracellular Ca2+ in PC3 human prostate cancer cells'. Together they form a unique fingerprint.

Medicine and Dentistry